Diversa Corporation (DVSA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Diversa Corporation (DVSA)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (121)	1/12/2006 11:18:13 AM
From: A.J. Mullen	Read Replies (1) of 144

I listened to the recording of the Diversa presentation at JP Morgan last night. I posted this on Biotyech Valuation. Interesting that they outline that they're getting out of pharmacology and most healthcare at a healthcare conference. They aim to concentrate on industrial enzymes. They're continuing with their antibody optimization though. Companies they work with are: Merck, Syngenta, BAyer, Dansier, Mederex, and Xoma. They separate "alternative energy" from industrial enzymes but they're AE application is cocktails of enzymes to speed production of ethanol from biomass. This is with Du Pont and Valley Research and gets government help. They also have an enzyme that speeds bleaching of wood pulp with BASF amongst others. I like the idea of Diversa moving towards industrial processes - with information on microbes from deep-sea vents and Yellowstone hotsprings, they should be in a good position. I went to the company's website though and listened to the original announcement of these changes. It seems these enzymes are not selling to well either. I also wonder about biomass to ethanol. Others are working on producing gas from biomass and then producing diesel.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next